Alira Health Appoints Dr. Susanne Schaffert as Senior Advisor and Patient-Centric Ambassador [Yahoo! Finance]
Novartis AG (NVS)
Last novartis ag earnings: 4/28 01:00 am
Check Earnings Report
US:NYSE Investor Relations:
novartis.com/investors
Company Research
Source: Yahoo! Finance
Susanne Schaffert as Senior Advisor and Patient-Centric Ambassador. Dr. Schaffert is a highly respected biopharmaceutical leader whose career includes senior executive roles and multiple Board of Directors positions across the healthcare sector. Dr. Schaffert previously served as President of Novartis Oncology and as a member of the company's Executive Committee, where she deepened her commitment to patient-centered thinking in oncology and distinguished herself as an innovator in advancing new approaches to care. This experience guides her role as an ambassador for patient-centered innovation. At Alira Health, Dr. Schaffert will work closely with the leadership team to guide patient-centered strategic initiatives and support the continued development of Alira Health's integrated work across life sciences. She will support the organization's mission and help guide its work with the benefit of her broad experience in healthcare. By uniting executive insight with patient advocacy, s
Show less
Read more
Impact Snapshot
Event Time:
NVS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVS alerts
High impacting Novartis AG news events
Weekly update
A roundup of the hottest topics
NVS
News
- ???????????????????? : ???????????????2033????559????????????????????????(CAGR)6.25%??????? [CNET News]CNET News
- FDA commissioner unveils major reform to fast-track drug innovation [FOX Business Network]FOX Business Network
- Has Novartis' 24.5% Surge Left Further Upside After Strong Pipeline and Cash Flow Gains? [Yahoo! Finance]Yahoo! Finance
- Novartis (NVS) Enters $1.7 Billion Development Deal, Says Report [Yahoo! Finance]Yahoo! Finance
- Novartis breaks ground on flagship manufacturing hub in North Carolina [Yahoo! Finance]Yahoo! Finance
NVS
Earnings
- 10/28/25 - Miss
NVS
Sec Filings
- 11/25/25 - Form 6-K
- 11/20/25 - Form 6-K
- 11/5/25 - Form 6-K
- NVS's page on the SEC website